Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Abbott Laboratories BDR (ABTT34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
46.33 0.00    0.00%
- Closed. Currency in BRL ( Disclaimer )
Type:  Equity
Market:  Brazil
ISIN:  BRABTTBDR007 
  • Volume: 0
  • Bid/Ask: 44.34 / 49.94
  • Day's Range: 46.00 - 46.33
Abbott Laboratories BDR 46.33 0.00 0.00%

ABTT34 Balance Sheet

 
Featured here, the Balance Sheet for Abbott Laboratories BDR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets - 22670 22664 23505
Cash and Short Term Investments - 7279 7047 8155
Cash - - - -
Cash & Equivalents - 6896 6709 7835
Short Term Investments - 383 338 320
Total Receivables, Net - 6565 6499 6172
Accounts Receivables - Trade, Net - 6565 6499 6172
Total Inventory - 6570 6650 6871
Prepaid Expenses - 2087 2101 2082
Other Current Assets, Total - 169 367 225
Total Assets - 73214 72090 73354
Property/Plant/Equipment, Total - Net - 11276 9552 9449
Property/Plant/Equipment, Total - Gross - 23055 21111 20926
Accumulated Depreciation, Total - -11779 -11559 -11477
Goodwill, Net - 23679 23277 23258
Intangibles, Net - 8815 9282 9834
Long Term Investments - 485 497 494
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 6289 6818 305
Other Assets, Total - 557 856 7753
Total Current Liabilities - 13841 13042 14350
Accounts Payable - 4295 3961 4211
Payable/Accrued - - - -
Accrued Expenses - 6543 6635 6505
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - 1325 1064 2284
Other Current liabilities, Total - 1678 1382 1350
Total Liabilities - 34387 34396 35950
Total Long Term Debt - 13599 14635 14704
Long Term Debt - 13599 14635 14704
Capital Lease Obligations - - - -
Deferred Income Tax - 568 - -
Minority Interest - 224 213 230
Other Liabilities, Total - 5736 6105 6253
Total Equity - 38827 37694 37404
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 24869 24727 24612
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - 37554 36920 36355
Treasury Stock - Common - -15981 -15686 -15722
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -7615 -8267 -7841
Total Liabilities & Shareholders' Equity - 73214 72090 73354
Total Common Shares Outstanding - 1734.08 1736.06 1735.36
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABTT34 Comments

Write your thoughts about Abbott Laboratories BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email